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fibropapilloma-associated herpesvirus among
clinically healthy sea turtles
Alonzo Alfaro-Núñez1*, Mads Frost Bertelsen2, Anders Miki Bojesen3, Isabel Rasmussen1,
Lisandra Zepeda-Mendoza1, Morten Tange Olsen1 and Marcus Thomas Pius Gilbert1,4Abstract
Background: Fibropapillomatosis (FP) is a neoplastic disease characterized by cutaneous tumours that has been
documented to infect all sea turtle species. Chelonid fibropapilloma-associated herpesvirus (CFPHV) is believed to
be the aetiological agent of FP, based principally on consistent PCR-based detection of herpesvirus DNA sequences
from FP tumours. We used a recently described PCR-based assay that targets 3 conserved CFPHV genes, to survey
208 green turtles (Chelonia mydas). This included both FP tumour exhibiting and clinically healthy individuals. An
additional 129 globally distributed clinically healthy individual sea turtles; representing four other species were also
screened.
Results: CFPHV DNA sequences were obtained from 37/37 (100%) FP exhibiting green turtles, and 45/300 (15%)
clinically healthy animals spanning all five species. Although the frequency of infected individuals per turtle
population varied considerably, most global populations contained at least one CFPHV positive individual, with the
exception of various turtle species from the Arabian Gulf, Northern Indian Ocean and Puerto Rico.
Haplotype analysis of the different gene markers clustered the CFPHV DNA sequences for two of the markers (UL18
and UL22) in turtles from Turks and Caicos separate to all others, regardless of host species or geographic origin.
Conclusion: Presence of CFPHV DNA within globally distributed samples for all five species of sea turtle was
confirmed. While 100% of the FP exhibiting green turtles yielded CFPHV sequences, surprisingly, so did 15% of the
clinically healthy turtles. We hypothesize that turtle populations with zero (0%) CFPHV frequency may be attributed
to possible environmental differences, diet and/or genetic resistance in these individuals. Our results provide first
data on the prevalence of CFPHV among seemingly healthy turtles; a factor that may not be directly correlated to
the disease incidence, but may suggest of a long-term co-evolutionary latent infection interaction between CFPHV
and its turtle-host across species. Finally, computational analysis of amino acid variants within the Turks and Caicos
samples suggest potential functional importance in a substitution for marker UL18 that encodes the major capsid
protein gene, which potentially could explain differences in pathogenicity. Nevertheless, such a theory remains to
be validated by further research.
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Studies on the evolution of pathogen virulence and host
resistance have shown that within populations, both patho-
gen and host are able to adapt in response to the interac-
tions [1,2]. However, there is much debate on how these
micro-evolutionary scale changes can influence the
patterns of speciation of the interacting species at macro-
evolutionary levels [2]. Co-evolution does not necessarily
lead to the co-speciation of the interacting species [3].
However, co-adaptation theory suggests a general trend of
parasite specialization for their hosts [4], regardless of the
age of the association. Retroviruses and herpesviruses,
with their vertebrate hosts, are good examples of
specialist pathogens for which co-evolution leading to a
host-specific occurrence over long periods of time and are
exquisitely well adapted to their host [5-7]. Thus, herpes-
viruses are well adapted to their hosts, most likely as a
consequence of prolonged co-evolution [6-8]. Herpesvi-
ruses are generally characterized by their variable host
range, short replication cycle, and the ability to destroy in-
fected cells and establish latent infection [9]. Within these
features of herpesviruses pathogenesis, we particularly
emphasize on latency, which is defined as persistent life-
long infection of a host with restricted, but recurrent,
virus replication [10].
Fibropapillomatosis (FP) is a debilitating neoplastic
disease that globally affects sea turtles, and is characterized
by the presence of epithelial fibropapillomas and in-
ternal fibromas [11,12]. Originally described in green turtles
(Chelonia mydas), FP has subsequently been documented
among all seven species of sea turtles [8,11,13-18] in all
major oceans, and thus has a circumtropical distribution
[19]. Prevalence estimates based upon FP records varies
among locations, ranging from as low as 1-2% to as high
as 90% [11], thus FP has been described as an emerging
disease with sporadic, but generally increasing, occur-
rence [12]. While environmental aspects are suspected
to be cofactors for the outbreaks [20,21], the Chelonid
fibropapilloma-associated herpesvirus (CFPHV) has been
proposed as the etiologic agent responsible [14,20]. As
with most other herpesvirus infections, CFPHV infections
are believed to result in a long, balanced interaction with
the turtle host, thus allowing efficient virus transmission
for years: lifelong latent infection is established only
interrupted by episodes of viral reactivation and potential
replication [22,23]. As such, sea turtles may be infected,
thus carrying entire segments of viral DNA and/or even
the entire viral particle, even when no FP tumours can be
observed.
Despite the consistent PCR-based detection of herpes-
virus DNA sequences in FP tumour samples [14,15,24], at-
tempts to cultivate CFPHV in vitro have been unsuccessful
[24]. Consequently the role of CFPHV as the causative
agent for FP tumours remains inconclusive.Given CFPHV’s putative causal role in FP, to date most
studies into the epidemiology, pathology, DNA detec-
tion, prevalence and phylogeography of CFPHV have
been performed using DNA extracted from tumour
tissue [8,19,24,25], thus cannot be used to estimate the
prevalence of latent CFPHV infections. While a small
number of studies have attempted to detect and quantify
viral DNA from tumour free tissue [12,26-28], the sam-
ples used were either from known FP infected animals,
or from localized populations known to be infected by
the virus. Thus, the global viral prevalence in turtles that
do not exhibit tumours remains unknown. Furthermore,
to date only a limited number of studies have attempted
to investigate amino acid substitutions within CFPHV
sequences, whether for determining phylogenetic relation-
ships of different CFPHV strains or long-term virus/host
co-speciation [8,29].
In this study, we used a recently validated PCR assay
that targets three short regions of conserved genes [18]
within the herpesvirus, to provide insights and evidence
into the prevalence, co-evolution, phylogeography and
genetic variation of CFPHV in tumour and non-tumour
containing samples of sea turtles. The dataset studied
included FP tumours from green turtles sampled from
three different distant populations; Hawaii in the Pacific,
Turks and Caicos [30] in the Caribbean, and Principe
Island [31] off the Western Coast of Africa, as well as tissue
samples from clinically healthy (not FP exhibiting) green,
loggerhead (Caretta caretta), olive Ridley (Lepidochelys
olivacea), hawksbill (Eretmochelys imbricata) and leatherback
(Dermochelys coriacea) sea turtles from globally-distributed
populations.
Results
Viral detection and prevalence
A total of 398 DNA extracts from 337 individual sea
turtles were screened for herpesvirus by PCR. In turtles
that presented more than one area of suspected FP
tumour, samples were collected from each suspected
site. CFPHV sequences were obtained from 132 samples
derived from 82 individual turtles, representing 24% of
the total sea turtles analysed. 100% of the 66 FP tumour
biopsy extracts (representing 37 individual green turtles)
were positive for CFPHV. Viral sequences were also
detected in 88% of the non-tumour DNA extractions from
the same FP infected green turtles. The average detection
level among the clinically healthy sea turtles (including
green turtles) was 15% (Table 1).
Of the 208 total green turtles analysed (FP exhibiting
and clinically healthy), 61 (29%) were PCR positive for
CFPHV. For the other species, all of which were repre-
sented by clinically healthy animals only, 20% of the 20
leatherback turtle samples, 12% of the 61 loggerhead
turtles, 15% of the 20 olive Ridley turtles and 25% out of
Table 1 Percentage of CFPHV detection by turtle species
Turtle species common name Number of turtle
individuals analysed
Results from PCR CFPHV detection by
type of tissue
Total turtles
detected
CFPHV positive
% of CFPHV
detection
by turtle speciesFP exhibiting healthy + CFPHV CFPHV free
Green (Cm) 208 37 24 147 61 29.3%
Loggerhead (Cc) 61 0 7 54 7 11.5%
Leatherback (Dc) 20 0 4 16 4 20.0%
Hawksbill (Ei) 28 0 7 21 7 25.0%
Olive Ridley (Lo) 20 0 3 17 3 15.0%
Total sea turtle individuals analysed 337 37 45 255 82 24.3%
Summary table of number of turtle species individuals analysed for Chelonid fibropapilloma-associated herpesvirus (CFPHV) DNA. Results are listed as either
CFPHV positive in FP exhibiting turtles clinically healthy carrying CFPHV DNA, or CFPHV free (CFPHV negative) in clinically healthy turtles. For detailed description
of population species see Additional file 2.
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marized PCR results, population origin of turtle species
DNA extracts analysed, minimum CFPHV prevalence es-
timated and detailed average detection per populations
species are listed in Additional files 1 and 2.
Sequencing, evolutionary models and haplotype analysis
All 132 viral positive DNA extractions were sequenced for
one or more of the three loci. Detailed list of haplotype
sequence SNPs per marker can be found in Additional
file 3. CFPHV DNA and amino acid sequences and haplo-
type SNPs detected were deposited in Dryad repository,
with reference number DOI:10.5061/dryad.8r082 [32]. The
final 98 nucleotide alignment of the 58 sequences for
UL18 locus exhibited five different variable sites (position
6 R, position 12 Y, position 40 Y, position 69 R and
position 78 R). The 132 nucleotide alignment of the 95sequences for UL22 locus contained two variables sites
(position 42 R and position 90 W). Finally, the 144 nucleo-
tide alignment of the 75 sequences for UL27 locus yielded
two variables sites (position 23 R and position 127 Y).
Using the Bayesian Information Criterion (BIC), the
Kimura (K80) substitution model was selected for the
alignment in UL18, whereas Jukes & Cantor (JC69)
was determined for the alignments in UL22 and UL27
(Additional file 4).
Topologies for UL18 and UL22 phylogenetic trees
followed a similar pattern clustering most viral sequences
originated from Turks and Caicos into a separate branch,
while the rest of sequences across species and locations
were clustered into a main branch. Moreover, one unique
green turtle viral sequence from Portugal, respectively for
UL18 and UL22, was also clustered into this alternative
branch. The phylogeny for UL27 did not provide
Figure 1 CFPHV global detection, haplotype networks and AA protein structures. (A) Global CFPHV detection given as proportion of each
turtle species’ populations. Different colours represent category of tissue sample and infectivity status as follows; Orange = FP exhibiting turtles
found CFPHV positive, Yellow = clinically healthy turtles also CFPHV positive, and Green = clinically healthy turtles CFPHV negative (CFPHV free),
(B) Percentage of CFPHV turtle infectivity grouped by different turtle species (same colour code as panel A), (C) Regional haplotype networks for
markers UL18, UL22 and UL27 clustered by regional sample origins, and showing the respective number of haplotypes found per marker, and
(D) Amino acid radical substitution-predicted protein structure models for marker UL18, where globally distributed samples have the reference
structure, while green turtles from Turks and Caicos, plus one green turtle from Portugal correspond to the alternative variant structure.
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sequences into three distinct branches showing no pattern
(Additional file 5).
Haplotype networks for UL18 and UL22 loci were in
agreement with the phylogenetic trees, showing a separate
regional unique haplotype for samples originated from
Turks and Caicos in the Caribbean and one unique sample
from Portugal in the North Atlantic (See Figure 1C).
However, no geographic structure was discernable for the
three different haplotypes detected for marker UL27.
Predicted effect of amino acid changes
The UL18-Viral Capsid exhibited a Y/C amino acid variant
at position 100 of the protein reference sequence
(protein_id: AHA93343.1). All 11 of the Turks and
Caicos green sea turtle samples, and one of the twoPortuguese samples exhibited the Y form representing a
20.7% of the total UL18 viral sequences, while all other
samples studied exhibited the C (79.3%). The structural
effect of the substitution in comparison to the reference
sequence was analysed using in silico 3D modelling. The
amino acid substitution may fall in a determined protein
domain with or without a reference template from Protein
Data Bank (PDB) [33] for the 3D modelling and the result-
ing model comes from a different number of predictions.
According to the structures modelled for the entire
protein sequence, the reference amino acid was positioned
in a beta SS3 domain in 73.5% of the RAPTORX pre-
dictions, in 11% of the predictions it fell in a helix and in
15.5% in a loop. This domain was modelled without the
use of a template from PDB due to lack of them. The
solvent accessibility for the reference amino acid was
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(10.1%). The alternative amino acid also was placed in a
beta structure with 81.3% (4.3% as helix and 14.2% loop)
according to the labelling of the whole sequence almost
entirely modelled using a template from PDB (93% of the
residues were modelled using a template, the alternative Y
amino acid included). In the 3D domain predicted from
PDB templates with a p value of 1.31e-02 100Y fell at the
end of a loop, right before the beginning of a beta. The
solvent accessibility for Y was labelled as buried (48%),
medium (38.2%), and exposed (13.9%). The predicted
structures of the reference and the sequence associated
with the radical amino acidic substitution were different,
with the first predicting two domains and the later
predicting three domains (See Figure 1D).
Marker UL22-Glycoprotein H also contains variation of
the protein reference sequence (protein_id: AHA93347.1),
with a variant codon (E/D) at position 126; 126 E mainly
corresponds to samples from Turks and Caicos, 126 D to
the rest of the world. 78% of the residues could be
modelled with a PDB template. The reference amino acid
form this conservative amino acidic change fell in a loop
with 64.3%, with no PDB template. 126 D was positioned
very close to a modelled with PDB template in a region
with a long loop, further supporting its loop classification.
Finally as UL27-Glycoprotein B, a codon variant was
identified as T/M at position 837 also of the protein
reference sequence (protein_id: AAU93326.1). This amino
acid variant exhibits no obvious phylogeographic distribu-
tion by species or population. 93% of the residues could
be modelled with a PBD template, not including 837 T,
but it fell very close to a modelled long loop region with
PDB template, further supporting its loop classification.
Discussion
Prevalence, co-evolution and latency
Although previous analyses have assayed the prevalence of
the FP disease among turtles, our results provide first data
of the prevalence of CFPHV among apparently healthy
turtles, something that may not be directly correlated to
the disease incidence, but directly provides evidence
suggesting a long-term co-evolutionary latent infection
interaction between CFPHV and its turtle-host across
species. This is not surprising, as the host-specific
occurrence of herpesviruses has been well documented,
suggesting they have evolved with their hosts over long
periods of time [5,6]. A specific host response to infectious
agents is suspected to be highly heritable, but recognizing
the genetic variants that may responsible for the disease
susceptibility and pathogenicity has proven challenging
[34]. A main goal in infectious disease research is to
identify the host-pathogen genetic variants that may ex-
plain differences in pathogenesis. Disrupted co-evolution
between host-pathogen interactions have recently beenproposed to explain the variation in disease outcomes,
which until now have not been able to be proven adequate
to explain the heterogeneity of disease pathology [34].
This clearly incorporates the limiting factor that both host
and pathogen genetic profile must be taken into account
when studying disease aetiology in order to draw conclu-
sions. Co-evolutionary theories support the hypothesis
that the processes of co-adaptations would lead to a
general trend of parasite specialization for their hosts [4],
regardless of the age of the association. However, it is
important to bare in mind that co-evolution does not
necessarily lead to the co-speciation of the interacting
species [3]. This long term co-divergence between CFPHV
with its turtle hosts has been addressed and analysed
previously, estimating that virus and host have co-evolved
for at least 8.9 million of years (Ma) [8]. A subsequent
study that reported the sequence of a large proportion of
the CFPHV genome, for use in investigating its phylogen-
etic structure across the global distribution of marine
turtle species, similarly concluded that co-evolution
happened over a scale of millions of years [35]. We
acknowledge that the dataset presented in this study is
small in terms of length of sequence analysed uniquely for
the herpesvirus. Additionally, DNA sequences of the same
length were downloaded from the database at GenBank in
order to analyse the phylogeny more in detail. For UL18
and UL22 markers only two other sequences of the same
length position were found. Nonetheless the sequences
could not be used as for origin location of the samples
was missing. For UL27 marker, 21 other viral sequences
were found and tested. K80 was selected as substitution
model for phylogeographic analysis of the new dataset.
Nevertheless the phylogenetic results of alignment did
not provide species or geographic structure distribut-
ing the sequences across five branches without a
distinctive pattern (see Additional file 6). Consequently,
we caution the general interpretation of the phylogenetic
results presented here, which may not reflect the real
genetic structure and distribution of the CFPHV.
However, our data includes a large number of samples that
span a considerable number of different geographic
locations, across five turtle species. Thus our data points
to the fact that the emergence of fibropapillomatosis
epizootics at multiple locations around the world during
the past decades is unlikely to be due to recent virulence
mutations in the virus, because it is highly improbable that
such mutations could occur independently in lineages [13].
Another aspect playing an important role in this
research is latency. Herpesviruses have the ability to
establish latent infections in their host, during which
viral gene expression is minimized [5]. Moreover, some
oncogenic herpesviruses induce tumour formation in
specific tissues [20], while being absent in other tissues
of the same individual. Latency is generally maintained
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latency [36]. Expression of these latency-associated genes
may function to keep the viral genome from being
digested by cellular ribozymes or being found out by the
immune system. Thus, CFPHV DNA may be unequally
distributed within same animal with large concentrations
of viral DNA in the affected tissue only. Given this, it is
not surprising that CFPHV viral DNA sequences were
detected in 100% of FP tumours. Although only 88% of
the samples derived from non-tumour areas of FP exhibit-
ing turtles were CFPHV positive, this is also unsurprising
- while in the active viraemic phase, herpesvirus DNA is
prone to be detected throughout the body, it is likely that
in chronic infections viral activity may be confined to
nervous tissue [5,37] and tumour sites.
Lastly, in the globally distributed samples of clinically
healthy individuals belonging to 5 species of sea turtles,
the average detection rate was substantially lower; 15%.
While we observed a great variation in the ratio of in-
fected individuals in the populations investigated, nearly all
sea turtle populations analysed counted some individuals
carrying CFPHV (see Figure 1A), which seems to support
the panzootic status of FP [11,38]. Excluding location
samples from which only a single individual was analysed -
e.g. loggerhead sample from Northern California or green
turtle from Danish aquarium -, unique exceptions seem
to be grouped in the small sample sizes originated from
Kuwait, Dubai and Oman in the Arabian Gulf and
Northern Indian Ocean, as well as hawksbill turtles from
Puerto Rico which remained CFPHV free in our global
PCR analysis (see Figure 1A). This could indicate that the
specific turtle individuals analysed in these areas could be
resistant to CFPHV and/or suggest that certain environ-
mental conditions possibly in combination with immune
system modulators may influence the persistence and
severity of the disease [11,39-42]. There are no historic
records for turtles exhibiting FB tumours for the entire
Arabian Gulf region, nor for the hawksbill population in
Puerto Rico. However, CFPHV presence was detected in
three-hawksbill turtles from Kuwait. Thus, apparently
CFPHV-free turtle populations should be observed indi-
vidually and not as a regional phenomenon. Moreover,
there is no genetic data available for green turtles nesting
at Qaru Island in Kuwait, however, satellite telemetry data
suggests this population derive from a larger stock nesting
in Saudi Arabia [43]. In order to analyse the large geo-
graphical distribution of Masirah Island’s loggerhead
population, a total of 34 turtle individuals were collected
over 80 kilometres coastline from the Omani population.
This population stock in combination with the rest of the
Indian Ocean has been estimated to be second largest
loggerhead population in the world [44,45], as well as
possessing one of the unique haplotypes in their clade,
which diverges from the remaining Atlantic and IndianOcean haplogroup IB lineages [46]. It is important
however, to acknowledge the small sample sizes used
in this study for both FP infected and non infected
turtle individuals, as this may not fully represent the actual
CFPHV infectivity prevalence.
Herpesviruses are frequently detected in tortoises and
terrapins of zoological collections mainly because of the
advances in diagnostic methods, and several species, mainly
tortoise herpesvirus 1 to 4 (THV1-4), have been reported
and characterized [39,47-49]. As our PCR primers used
were all based on published sequences of conserved genes
[6,50] in the CFPHV genome, we speculated they may
potentially anneal successfully to related herpesviruses.
However, a preliminary result from a small data set of 11
DNA extracts derived from 9 different species of tortoises
and terrapins (Additional files 3 and 7) yielded no positive
results. Whether this indicates that CFPHV is unique to sea
turtles, or that tortoise and terrapin herpesvirus is too
divergent for the primers to bind to remains uncertain, and
warrants future investigation.
Herpesviruses are well known to be transmitted hori-
zontally from one infected organism to the other by direct
physical contact via saliva, mucus, blood or semen [6].
Viral particles can also be transported and survive in salt
water for relatively short periods of time before the pro-
teins in the virus capsid degrade. This has been reported
for the herpesvirus associated with lung-eye-trachea
disease (LETD) in sea turtles, which has been shown to
survive in seawater for about 2 weeks [51]. Sea turtles have
been observed to develop FP tumours as juveniles and
it has been suggested that infection occurs in feeding
grounds where animals conglomerate in large numbers
[13,52]. It is possible to hypothesize, therefore, that the
transmission of the virus occurs mainly during this period
in the life cycle of sea turtles. Thus, animals may either
develop infection or simply remain passively infected in
latency while viral DNA establishes into the animal tissue
for the rest of their life. Moreover, we speculate that
severity of infection may depend on co-infections and the
immunological status of the individual animal, which also
may explain why not all animals in a population develop
FP [38].
We hypothesize that there is little or no chance for
vertical disease transmission from mother to offspring as
it has been suggested before for sea turtles. However, there
is a possibility of heritable-genetic disease susceptibility
prior exposure to whatever the infectious agent is, as pre-
viously proposed by Herbst et al. in 1995 [20]. The only
population that we obtained neonate samples from was
Tortuguero green turtles in the Caribbean of Costa Rica.
Samples from this stock were analysed for nesting females
(n = 41) and offspring (n = 59) from 6 different clutches.
One nesting female, which was the mother of one clutch
analysed, was CFPHV positive (UL22), 10 of its offspring
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detected only from six females in this population; all
offspring neonates resulted in zero prevalence. While our
data is not conclusive, future studies should examine the
genetic signature mother-offspring in viral disease trans-
mission and tumour development.
Amino acid variation in the Turks and Caicos population
From the different amino acid substitutions found in the
haplotypes, only the C > Y radical substitution at
position 100 in the UL18 marker gene is of potential
functional importance. All other substitutions observed
were either conservative, or part of a loop. Although no
high-resolution crystallographic structure exists for the
protein encoded by this gene, thus limiting the potential
for functional prediction, it was possible to use RAP-
TORX to predict structural changes with other suitable
templates. Modelling of the 100 YC substitution indi-
cates a significant difference between the reference and
the alternative sequence, with the alternative sequence
having an extra domain compared to the reference (See
Figure 1D). This could be due to the availability of
more PDB templates for the alternative sequence, or
reflect an actual change in the protein folding due to
this particular residue which has high probabilities of
forming part of a beta ladder or at least be right before
the beginning of one, suggesting its importance to the
protein structure. This is of increased interest when
taking into account the characteristics of these two
amino acids, as the cysteine has a thiol side chain group
that often engages in enzymatic reactions, and its oxi-
dized form, cysteine, has an important structural role in
many proteins. On the other hand, the tyrosine has a
phenol side chain group, which allows it to receive a
phosphate from kinases in signal transduction cascades,
changing the activity of the protein. Given that the
function of the major capsid protein is to protect the
viral genome from damaging agents such as proteolytic
and nucleolytic enzymes, such an amino acidic change
could have functional as well as structural implications.
FP tumours have previously been reported for green
turtles in Turks and Caicos Islands (TCI’s) [30,53], but no
genetic characterization has been done of the infected
animals at this location. Mixed-stock analysis of conglom-
erating green turtles from TCI’s, have shown the mito-
chondrial haplotype CM-A3 as the most common, a
widespread haplotype in Caribbean rookeries, including
Costa Rica (Tortuguero), Florida and Mexico [30]. This
indicates that TCI’s green turtle aggregations may receive
important contributions from all over the Caribbean and
possibly also from the rest of the Atlantic. However, there
is no evidence suggesting a genetic flow between these
and populations from far Northeast or from the other side
of the Atlantic e.g. in Portuguese waters. Both haplotypeand amino acids characterization performed in this study
indicate a unique genetic signature for the CFPHV in
TCI’s, shared only by one sample originated in Portugal,
which may suggest this virus strain has spread across the
Atlantic. It is important to notice that all turtles from
TCI’s containing this virus strain were FP exhibiting, while
the unique turtle from Portugal was a clinically healthy
animal with no signs of disease. Furthermore, the amino
acid substitution described for UL18 gene may as well
suggest an important protein structure modification that
could potentially result in the viral capsid being more
resistant to the host immune system. As has been shown
before, even a single amino acid substitution can be the
cause of viral drug resistance and enhanced virulence
[54-56]. Even though its positioning in the protein struc-
ture is based only on computational modelling and the
validity of its importance is subject to different conditions,
such as the amino acid being at least moderately exposed
instead of buried, it is worth noting it as a target for future
deeper analysis with laboratory experimental techniques.
Conclusions
Our data reveals the presence of CFPHV DNA within
globally distributed samples for all five species of sea turtle
(See Figure 1A-B). While the 100% incidence of CFPHV
in samples taken from tumour exhibiting green turtles is
in concordance with the findings of previous studies
[27,28,51,52], the key new observation is a non-negligible
prevalence among clinically healthy animals of all 5
species. Surprisingly this yielded an average of 15% of
CFPHV infected individuals, and evidences the latent
infectivity co-evolutionary process across virus and host.
While the frequency of infected turtle individuals from
the different sites varied considerably, as well as the sam-
ple sizes studied, most global sample sets contained at
least one CFPHV positive individual. One notable excep-
tion is that of the various turtle species from the Arabian
Gulf and Northern Indian Ocean, as well as hawksbill
turtles (Eretmochelys imbricata) from Puerto Rico, which
were CFPHV free. We hypothesize that this may suggest a
possible environmental difference and/or genetic resistance
in these individuals.
Haplotype analysis results were in agreement for markers
UL18, UL22 (See Figure 1C); clustering CFPHV DNA
sequences in turtles from Turks and Caicos separate to all
others, regardless of host species or geographic origin.
Larger nucleotide amps to full genomic data are advised to
be used to address phylogeography and genetic relation-
ships within the CFPHV clade.
Finally, computational analysis of amino acid radical
substitution variants within the Turks and Caicos samples
suggest potential functional importance in a substitution
for marker UL18 (See Figure 1D) that encodes the major
capsid protein gene. This could potentially explain
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different CFPHV genotypes at different locations. Further
research is however advised in order to validate our
suggested theory.
Methods
Samples
Tissue sampling design and protocols varied among the
different collaborators who provided samples from across
the world. Overall, 398 tissue samples from 337 individual
turtles of five species of sea turtles were obtained, taken
from skin, FP tumours or blood. Sample material obtained
were categorized into three different groups for analysis;
1) tumours from turtles exhibiting FP, 2) any other type of
tissue with macroscopic absence of tumour (non-tumour)
taken from FP exhibiting turtles; and 3) any type of tissue
or blood from clinically healthy (not FP exhibiting) turtles.
FP tumour samples derived from three populations of
green turtles: Hawaii in the Pacific, Turks and Caicos in
the Caribbean, and Principe Island off the Atlantic coast
of Africa. For other tissue samples from clinically healthy
turtles (thus not FP exhibiting) see details in Additional
file 7. All samples were collected and exported under
CITES permits (host institute permit DK03).
Skin samples were preserved in either RNA later®
(Qiagen), DMSO 20% saturated with NaCl or in 70-96-
100% ethanol at -20°C; blood samples were preserved in
PAXgene™ (Qiagen).
DNA extraction of skin and tumour samples
DNA was extracted from approximately 25 mg tissue
using the DNeasy Kit (Qiagen, Valencia, CA) following
the instructions of the manufacturer. Samples were incu-
bated with agitation for 24 h at 56°C. The samples were
then centrifuged for 5 min at 10,000 g to pellet any
remaining cellular material and the supernatant was trans-
ferred into a 2 ml DNeasy Mini spin column placed in a
2 ml collection tube and centrifuged for 1 min at 8,000 g.
Finally purified genomic DNA was eluted in 100 μl of
Qiagen EB buffer. Extraction blanks were included to
monitor for contamination.
DNA extraction from blood samples
DNA was extracted from approximately 10-20 μl anticoa-
gulated blood by proteinase K digestion using the DNeasy
Blood & Tissue Kit (Qiagen, Valencia, CA) following the
manufacturer’s instructions.
Samples were incubated with agitation for 10 min at
56°C. The samples were then centrifuged for 1 min at
10,000 g, ethanol 96% was added to each sample and the
supernatant was transferred into a 2 ml the DNeasy
Mini spin column placed in a 2 ml collection tube, and
then centrifuged for 1 min at 8,000 g and washed two
times with Qiagen AW1 and AW2 buffers and finallypurified genomic DNA was eluted in 200 μl of Qiagen
AE buffer. Extraction blanks were included to monitor
for contamination.
PCR assay
PCR protocol specifications from a recently developed
PCR-assay [18] were followed. The assay uses singleplex
primers designed to target highly conserved regions for
three different genes [6,50] in the herpesvirus genome
(Glycoprotein B gene UL27, Glycoprotein H gene UL22
and Mayor capsid protein gene UL18-UL19) (primer
sequences are listed in Additional file 8). To minimise the
risk of over estimating the prevalence, a conservative
approach was taken with regards to positive result
acceptance. Firstly, all PCR results were confirmed through
repeating the PCR at least twice. Secondly, every positive
viral amplicon identified was confirmed by Sanger
sequencing; any amplification that lacked sequence
verification was considered a false positive and excluded
from the analysis.
PCR amplicons of the expected size were purified using
QIAquick columns (Qiagen) following the manufacture’s
protocol, then sequenced in both directions by the
commercial service at Macrogen Inc., Europe. Negative
controls were included in each batch of PCR amplifications
and next sequencing reactions to detect contamination.
Data analysis
A total of 287 purified PCR amplicons were sequenced using
BigDye v3.1 (Applied Biosystems, USA) and 3730XL DNA
Analyzer (Applied Biosystems, USA) atMacrogen Inc., Europe.
DNA sequences were edited and aligned using GEN-
EIOUS PRO 6.1.7 (Biomatters Ltd.) to give a consensus
sequence for each amplicon. Thereafter, sequences were
blasted against NCBI GenBank and assigned to herpes-
virus based on minimum 95% pairwise identity. For any
BLAST result yielding a lower identity, the sequence was
manually re-checked, and considered false positive if the
sequence was not obviously derived from the herpesvirus
target and thus excluded from further analysis. Sequences
were truncated to alignments for each gene marker.
MAFFT v6.814b as implemented within GENEIOUS was
used to align the sequences for each amplicon marker,
using a scoring matrix of 200PAM/k2, gap open penalty:
1.53 and offset value: 0.123).
Phylogenetic analyses
Substitution model selection for each of the three aligned
fragment sets was inferred in JMODELTEST v2.1.6 [57,58].
The best-fitting model our of the 88 evolutionary models
were selected according to the BIC (Additional file 4) were
used for the phylogenetic analyses since this method is
known to perform better than other criteria [59].
Maximum likelihood trees were generated using PHYML
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region (1000 non-parametric bootstrapped data sets) to
illustrate the genetic relationship between the different
sequence samples and plotted in FIGTREE v1.4.2 [61]
(Additional file 5).
Haplotype analysis
Number of variable sites was determined and analysed for
each alignment for each gene short-fragment marker (UL18,
UL22 and UL27). Spatial distribution of virus strains was
visualized by creating haplotype networks using TEMPNET
[62], an R-script for summarizing heterochronous genetic
data implemented in R version 3.0.2 [63] with RSTUDIO
version 0.98.490.
Amino acid analysis
In order to identify any amino acid substitution that may
have functional implications between different virus haplo-
types, the sequences from each marker were aligned to the
corresponding gene sequence downloaded from NCBI
GenBank, then translated in the corresponding frame using
the standard genetic code. Subsequently, the sequence
structures of the marker proteins with and without the
amino acidic substitution were predicted with RAPTORX
[64] and the protein secondary structure in which the
changed amino acid fell was identified from the reported
structure labelling for the whole sequence as well as from
the 3D model for the corresponding domain when possible.
RAPTORX refers to a domain in the sense of a model unit.
Furthermore, the predicted structure model of the whole
sequence with the reference and alternative amino acid
were compared, as well as the predicted solvent accessibility
of the reference and alternative amino acid that reports a
probability of the amino acid being buried, exposed, or
moderately exposed.
Availability of supporting data
CFPHV DNA and amino acid sequences and haplo-
type SNPs detected were deposited in Dryad in the
Availability of Supporting Data section of this article,
with reference number DOI:10.5061/dryad.8r082 [32].
The haplotype and amino acid sequences list data set
supporting the results of this article are also included
in the Additional file 3.
Additional files
Additional file 1: Summarized list of DNA extractions analysed
grouped by population and turtle species; and Description of data.
Summarized results list of DNA extractions analysed grouped by population
and turtle species presented by each PCR assay per locus marker, total viral
detection and proportion of CFPHV infected turtles calculated by the total
number of DNA extracts.
Additional file 2: Detailed number of turtle species individuals
analysed for the CFPHV DNA detection (see Additional file 1);and Description of data. Listed results per turtle species as either CFPHV
positive in FP exhibiting turtles (orange colour) and clinically healthy
carrying CFPHV DNA (yellow colour), or CFPHV free (CFPHV negative)
uniquely for clinically healthy turtles (green colour).
Additional file 3: Haplotype and amino acid sequences list; and
Description of data. Detailed list of haplotype DNA sequences and
amino acid variants found for the highly conserved regions for three
short-fragments markers (UL18, UL22 and UL27) within the CFPHV
genome.
Additional file 4: Table list with the best inferred substitution models;
and Description of data. Detailed table list with the best inferred
substitution models using JModelTest software for the alignments of
the sequence data generated in this study for UL18, UL22, UL27 markers
and for the alignment of the same dataset for UL27 plus all the available
sequences at GenBank database.
Additional file 5: Circular maximum likelihood phylogenetic trees;
and Description of data. Circular maximum likelihood phylogenetic
trees for (A) UL18, (B) UL22 and (C) UL27 sequence alignments generated
in this study.
Additional file 6: Circular maximum likelihood phylogenetic tree
for UL27 + GenBank; and Description of data. Circular maximum
likelihood phylogenetic tree of combined alignment generated from
UL27 sequences produced in this study and available sequences found at
GenBank database.
Additional file 7: Detailed sample material analysed for CFPHV
detection; and Description of data. List of DNA extracts analysed
for DNA viral detection of the Chelonid fibropapilloma-associated herpesvirus
(CFPHV) including, sample ID, species, type of tissue, and population origin.
Moreover, PCR assay results by individual marker and confirmation of CFPHV
DNA by Sanger sequencing.
Additional file 8: Primer sequences; and Description of data.
Singleplex primer sequences designed to target highly conserved regions
for three different genes in the herpesvirus genome [18].
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